P
&Partners’s Invesco S&P 500 Equal Weight Health Care ETF RSPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $769K | Buy |
26,357
+190
| +0.7% | +$5.54K | 0.01% | 1122 |
|
|
2025
Q1 | $774K | Sell |
26,167
-194
| -0.7% | -$5.74K | 0.01% | 925 |
|
|
2024
Q4 | $772K | Sell |
26,361
-144
| -0.5% | -$4.22K | 0.01% | 879 |
|
|
2024
Q3 | $854K | Sell |
26,505
-89
| -0.3% | -$2.87K | 0.02% | 630 |
|
|
2024
Q2 | $799K | Sell |
26,594
-1,130
| -4% | -$33.9K | 0.04% | 402 |
|
|
2024
Q1 | $881K | Buy |
27,724
+5
| +0% | +$159 | 0.12% | 166 |
|
|
2023
Q4 | $825K | Sell |
27,719
-1,395
| -5% | -$41.5K | 0.2% | 114 |
|
|
2023
Q3 | $798K | Buy |
29,114
+25,993
| +833% | +$712K | 0.37% | 55 |
|
|
2023
Q2 | $930K | Buy |
3,121
+1
| +0% | +$298 | 0.42% | 46 |
|
|
2023
Q1 | $910K | Sell |
3,120
-70
| -2% | -$20.4K | 0.44% | 48 |
|
|
2022
Q4 | $920K | Sell |
3,190
-134
| -4% | -$38.7K | 0.46% | 47 |
|
|
2022
Q3 | $835K | Hold |
3,324
| – | – | 0.48% | 49 |
|
|
2022
Q2 | $890K | Sell |
3,324
-49
| -1% | -$13.1K | 0.51% | 40 |
|
|
2022
Q1 | $1.03M | Sell |
3,373
-125
| -4% | -$38.3K | 0.58% | 35 |
|
|
2021
Q4 | $1.12M | Sell |
3,498
-9
| -0.3% | -$2.88K | 0.68% | 31 |
|
|
2021
Q3 | $1.05M | Sell |
3,507
-45
| -1% | -$13.4K | 0.67% | 37 |
|
|
2021
Q2 | $1.04M | Sell |
3,552
-60
| -2% | -$17.6K | 0.67% | 38 |
|
|
2021
Q1 | $969K | Buy |
3,612
+1
| +0% | +$268 | 0.71% | 38 |
|
|
2020
Q4 | $945K | Buy |
3,611
+20
| +0.6% | +$5.23K | 0.79% | 34 |
|
|
2020
Q3 | $846K | Hold |
3,591
| – | – | 0.86% | 36 |
|
|
2020
Q2 | $798K | Buy |
3,591
+91
| +3% | +$20.2K | 0.96% | 27 |
|
|
2020
Q1 | $662K | Buy |
3,500
+1
| +0% | +$189 | 1.03% | 24 |
|
|
2019
Q4 | $775K | Sell |
3,499
-60
| -2% | -$13.3K | 0.92% | 30 |
|
|
2019
Q3 | $697K | Buy |
3,559
+1
| +0% | +$196 | 0.9% | 29 |
|
|
2019
Q2 | $721K | Hold |
3,558
| – | – | 1% | 25 |
|
|
2019
Q1 | $702K | Buy |
3,558
+75
| +2% | +$14.8K | 1.01% | 29 |
|
|
2018
Q4 | $618K | Buy |
+3,483
| New | +$618K | 1.04% | 29 |
|